Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$174.81 - $241.14 $1,048 - $1,446
-6 Reduced 17.65%
28 $7,000
Q1 2022

May 11, 2022

BUY
$166.16 - $213.96 $1,329 - $1,711
8 Added 30.77%
34 $6,000
Q4 2021

Jan 10, 2022

BUY
$184.32 - $216.08 $1,474 - $1,728
8 Added 44.44%
26 $6,000
Q3 2021

Nov 24, 2021

BUY
$179.86 - $214.88 $899 - $1,074
5 Added 38.46%
18 $3,000
Q4 2020

Jan 15, 2021

BUY
$101.87 - $151.79 $713 - $1,062
7 Added 116.67%
13 $2,000
Q2 2020

Jul 10, 2020

BUY
$92.74 - $125.82 $185 - $251
2 Added 50.0%
6 $1,000
Q4 2018

Feb 04, 2019

BUY
$101.4 - $128.73 $405 - $514
4 New
4 $0

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.